Emerging Roles of Src Family Protein Tyrosine Kinases in Diabetic Peripheral Neuropathy: Current Evidence and Therapeutic Perspectives
Diabetes, Metabolic Syndrome and Obesity · 2026-10 · Volume 19 · 1-12
DOI: 10.2147/dmso.s637555 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-10. Verfasst von Wenting Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colle…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes mellitus and is characterized primarily by distal symmetric polyneuropathy. Its pathogenesis involves multiple interconnected processes, including hyperglycemia, metabolic dysregulation, oxidative stress, neuroinflammation, and pain sensitization. Src family kinases (SFKs) are a group of non-receptor protein tyrosine kinases that are widely involved in cell proliferation, migration, inflammatory responses, synaptic plasticity, and ion-channel regulation. Recent evidence indicates that high glucose, advanced glycation end products, inflammatory mediators, and nerve injury-related stimuli can induce aberrant activation of SFKs, which may contribute to DPN-related neural injury and neuropathic pain. However, research on the involvement of SFKs in DPN remains relatively limited, and their specific roles and therapeutic value in DPN require further validation. On the basis of an overview of the structural features of SFKs, this review summarizes current evidence regarding the multiple mechanisms through which SFKs may participate in DPN and discusses the therapeutic prospects of SFK inhibitors, SFK-directed strategies, and traditional Chinese medicine approaches in DPN. The aim is to provide a reference for the development of SFK-targeted therapeutic approaches for DPN.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.
- Institute of Clinical Medicine, National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's…
ORCID-Profile: Wenting Wang
Zitieren
APA
Wang, W., Li, Z., Chen, Z., Cao, Y., Cao, H., Liu, S., Song, W., & Wu, Q. (2026). Emerging Roles of Src Family Protein Tyrosine Kinases in Diabetic Peripheral Neuropathy: Current Evidence and Therapeutic Perspectives. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-12. https://doi.org/10.2147/dmso.s637555
Vancouver
Wang W, Li Z, Chen Z, Cao Y, Cao H, Liu S, et al. Emerging Roles of Src Family Protein Tyrosine Kinases in Diabetic Peripheral Neuropathy: Current Evidence and Therapeutic Perspectives. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-12. doi:10.2147/dmso.s637555
BibTeX
@article{Wang2026,
author = {Wang, Wenting and Li, Ziyu and Chen, Zanpeng and Cao, Yuan and Cao, Hui and Liu, Shuainan and Song, Wei and Wu, Qunli},
title = {Emerging Roles of Src Family Protein Tyrosine Kinases in Diabetic Peripheral Neuropathy: Current Evidence and Therapeutic Perspectives},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--12},
doi = {10.2147/dmso.s637555}
}
EUVIMED